Early clinical experience and comparison between percutaneous and surgical arteriovenous fistula

Habib, Salim; Jano, Antalya; Ali, Adham N. Abou; Phillips, Amanda R.; Pinter, Joshua; Yuo, Theodore H.

doi:10.1016/j.jvs.2023.05.030

Cited by 3 publications

(1 citation statement)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Traditionally, it has been believed that excessive hemodialysis ultrafiltration, reduced blood flow, hypotension caused by hypovolemia, use of hemostatic drugs, and long‐term puncture at the anastomosis are the root causes of fistula blockage and failure in the vascular access. 4 However, some scholars believe that it is closely related to vascular wall damage, coagulation disorders, and immune/inflammatory responses. 5 In addition, studies have shown that inflammation at vascular access is also one of the main causes of arterial intimal hyperplasia and early thrombosis of local vessels.…”

Section: Introductionmentioning

confidence: 99%

Differential expression of serum TM, PAF, and CD62P in patients with autologous arteriovenous fistula and the correlation with vascular access function

Jiang,

Liu,

Liu

et al. 2024

Immunity Inflam & Disease

View full text Add to dashboard Cite

BackgroundEnd‐stage renal disease (ESRD) is the final stage of chronic kidney disease (CKD).AimsWe aimed to analyze the expression differences of serum thrombomodulin (TM), platelet‐activating factor (PAF), and P‐selectin (CD62P) in patients with autologous arteriovenous fistula (AVF) and the correlation with vascular access function.MethodsThe case data were retrospectively analyzed. Moreover, 160 patients with AVF maintenance hemodialysis were selected as the AVF group, and 150 healthy participants were selected as the healthy control group. According to the function of vascular access, patients in the AVF group were divided into Group A (n = 50, after the first establishment of AVF), Group B (n = 64, normal vascular access function after hemodialysis treatment), and Group C (n = 46, vascular access failure). Pearson analysis was conducted to explore the correlation between serum TM, PAF, CD62P content, and vascular pathological examination indicators, to evaluate the value of TM, PAF, and CD62P levels in predicting vascular access failure in patients with AVF.Results and DiscussionThe serum levels of TM, PAF, and CD62P were positively correlated with the expressions of CD68 and MCP‐1, respectively (p < .001). Serum TM was positively correlated with the levels of PAF and CD62P (p < .001), and PAF was positively correlated with the levels of CD62P (p < .001), respectively. Serum levels of TM, PAF and CD62P were risk factors for vascular access failure in AVF patients (p < .05). The area under the curve of serum TM, PAF and CD62P levels in predicting vascular access failure in AVF patients was 0.879.ConclusionThe serum levels of TM, PAF, and CD62P in AVF patients were correlated with the vascular access function of AVF patients, which was very important for maintaining the stability of vascular access function, and had certain value in predicting vascular access failure/disorder in AVF patients, and could be popularized and applied.

show abstract

Section: Introductionmentioning

confidence: 99%

Differential expression of serum TM, PAF, and CD62P in patients with autologous arteriovenous fistula and the correlation with vascular access function

Jiang,

Liu,

Liu

et al. 2024

Immunity Inflam & Disease

View full text Add to dashboard Cite

show abstract

Percutaneous Fistula Creation

Hull,

Mallios

2024

Principles of Dialysis Access

View full text Add to dashboard Cite

Is There Gender Disparity in Vascular Access for Hemodialysis with New Percutaneous Systems? A Systematic Review

Vergara-Pérez,

Pérez Alba,

Baliño

et al. 2024

Kidney and Dialysis

View full text Add to dashboard Cite

Background: Historically, a large gender-related disparity in vascular access (VA) has been demonstrated, with there being a lower prevalence of women with arteriovenous fistula (AVF) compared to men, and women have worse maturity rates. The cause of this difference is not entirely clear, although several reasons that could contribute to it have been hypothesized. The emergence of new percutaneous FAV (pFAV) systems could be an alternative for reducing these differences. Objective: This study aims to determine whether there is a gender difference in the creation of AVFs using new percutaneous systems. Material and Methods: A systematic review of the literature was conducted by searching PubMed and Google Scholar using the following terms: “percutaneous arteriovenous fistula”, “endovascular arteriovenous fistula”, and “hemodialysis”. All clinical trials, comparative studies, and descriptive studies involving patients who underwent a pAVF were included. Results: Finally, the review includes 19 studies, comprising 14 retrospective studies and 5 prospective studies. Of these, six studies are comparative, five of which compare pAVFs with surgically created AVFs (sAVFs), and one compares pAVFs performed using different systems with each other. A total of 1269 patients were included in the review. Of the total number of patients, only 414 were women, representing 32.62% of patients. Conclusions: The number of women included in the various studies analyzing pAVF remains very low, representing less than one-third of all patients. Although the causes of this difference are not entirely clear, several reasons have been hypothesized, such as socioeconomic factors, anatomical factors, or even patients’ preferences. Given these results, further studies are needed to try to clarify the reasons for this gender disparity and to establish different strategies to mitigate the barriers faced by women in accessing AVFs.

show abstract

Early clinical experience and comparison between percutaneous and surgical arteriovenous fistula

Cited by 3 publications

References 31 publications

Differential expression of serum TM, PAF, and CD62P in patients with autologous arteriovenous fistula and the correlation with vascular access function

Differential expression of serum TM, PAF, and CD62P in patients with autologous arteriovenous fistula and the correlation with vascular access function

Percutaneous Fistula Creation

Is There Gender Disparity in Vascular Access for Hemodialysis with New Percutaneous Systems? A Systematic Review

Contact Info

Product

Resources

About